Related references
Note: Only part of the references are listed.Human ether-a-go-go-related potassium channel: exploring SAR to improve drug design
Maria Maddalena Cavalluzzi et al.
DRUG DISCOVERY TODAY (2020)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Can Chinese Medicine Be Used for Prevention of Corona Virus Disease 2019 (COVID-19)? A Review of Historical Classics, Research Evidence and Current Prevention Programs
Luo Hui et al.
CHINESE JOURNAL OF INTEGRATIVE MEDICINE (2020)
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
David Gurwitz
DRUG DEVELOPMENT RESEARCH (2020)
Of chloroquine and COVID-19
Franck Touret et al.
ANTIVIRAL RESEARCH (2020)
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
Jianjun Gao et al.
BIOSCIENCE TRENDS (2020)
The Ebola clinical trials: a precedent for research ethics in disasters
Philippe Calain
JOURNAL OF MEDICAL ETHICS (2018)
Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective
Maria Maddalena Cavalluzzi et al.
EXPERT OPINION ON DRUG DISCOVERY (2017)
Repurposed Therapeutic Agents Targeting the Ebola Virus: A Systematic Review
Hussein Sweiti et al.
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL (2017)
An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel
William J. Crumb et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2016)
Examining the Ethics of Clinical Use of Unproven Interventions Outside of Clinical Trials During the Ebola Epidemic
Seema K. Shah et al.
AMERICAN JOURNAL OF BIOETHICS (2015)
Ebola therapy: Developing new drugs or repurposing old ones?
Giovanni Lentini et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2015)
Did Ebola Survivors Use Plant Medicines, and if so, Which Ones?
Solomon Habtemariam et al.
PHYTOTHERAPY RESEARCH (2015)
Synthesis of chiral chloroquine and its analogues as antimalarial agents
Manish Sinha et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
Ebola: Is there a hope from treatment with cardiovascular drugs?
Salvatore Patane
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Preparation of (-)-(R)-2-(2,3,4,5,6-pentafluorophenoxy)-2-(phenyl-d5)acetic acid: an efficient 1H NMR chiral solvating agent for direct enantiomeric purity evaluation of quinoline-containing antimalarial drugs
Maria Maddalena Cavalluzzi et al.
TETRAHEDRON-ASYMMETRY (2014)
Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'?
Giovanni Lentini
NATURE REVIEWS DRUG DISCOVERY (2012)
Collation, assessment and analysis of literature in vitro data on hERG receptor blocking potency for subsequent modeling of drugs' cardiotoxic properties
Sebastian Polak et al.
JOURNAL OF APPLIED TOXICOLOGY (2009)
The molecular basis of chloroquine block of the inward rectifier Kir2.1 channel
Aldo A. Rodriguez-Menchaca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Predictive models for hERG channel blockers: Ligand-based and structure-based approaches
Khac-Minh Thai et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
25 years of the WHO essential medicines lists: progress and challenges
R Laing et al.
LANCET (2003)
Proliferative growth of SARS coronavirus in Vero E6 cells
ML Ng et al.
JOURNAL OF GENERAL VIROLOGY (2003)
Molecular determinants of voltage-dependent human ether-a-go-go related gene (HERG) K+ channel block
JA Sánchez-Chapula et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
